Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation
about
MIP-T3, a novel protein linking tumor necrosis factor receptor-associated factor 3 to the microtubule networkT6BP, a TRAF6-interacting protein involved in IL-1 signalingImpaired neural tube closure, axial skeleton malformations, and tracheal ring disruption in TRAF4-deficient mice.Role of NF kappa B activator Act1 in CD40-mediated signaling in epithelial cellsMolecular basis for CD40 signaling mediated by TRAF3Effect of inositol hexakisphosphate kinase 2 on transforming growth factor beta-activated kinase 1 and NF-kappaB activationNF-κB, the first quarter-century: remarkable progress and outstanding questionsRoles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functionsHistorical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journeyTumor necrosis factor receptor-associated factors (TRAFs)NF-kappaB and the immune responseTumor necrosis factor receptor-associated factor 2 (TRAF2)-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signalingTRAF4 deficiency leads to tracheal malformation with resulting alterations in air flow to the lungsCD40 regulates the processing of NF-kappaB2 p100 to p52The Drosophila tumor necrosis factor receptor-associated factor-1 (DTRAF1) interacts with Pelle and regulates NFkappaB activity.A functional map of NFkappaB signaling identifies novel modulators and multiple system controls.Gene expression trees in lymphoid developmentThe CD40-TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells.TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRsThe adaptor TRAF5 limits the differentiation of inflammatory CD4(+) T cells by antagonizing signaling via the receptor for IL-6.Roles of the kinase TAK1 in TRAF6-dependent signaling by CD40 and its oncogenic viral mimic, LMP1Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1).Tumor necrosis factor receptor-associated factor (TRAF) 2 controls homeostasis of the colon to prevent spontaneous development of murine inflammatory bowel disease.Generation and analysis of Siah2 mutant mice.TNF-receptor-associated factors as targets for drug development.Lymphotoxin and LIGHT signaling pathways and target genes.Up-regulation and pre-activation of TRAF3 and TRAF5 in inflammatory bowel disease.Disruption of Tumor Necrosis Factor Receptor-Associated Factor 5 Exacerbates Murine Experimental Colitis via Regulating T Helper Cell-Mediated InflammationIntestinal protein expression profile identifies inflammatory bowel disease and predicts relapseRoles of TRAF molecules in B lymphocyte functionTRAF molecules in cell signaling and in human diseasesDiscrete functions of TRAF1 and TRAF2 in Drosophila melanogaster mediated by c-Jun N-terminal kinase and NF-kappaB-dependent signaling pathwaysTNF receptor-associated factor 5 is required for optimal T cell expansion and survival in response to infectionRANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolismTRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40.Molecular mechanism and function of CD40/CD40L engagement in the immune system.TRAF6 is a critical regulator of LMP1 functions in vivo.LTβR and CD40: working together in dendritic cells to optimize immune responses.The contextual role of TNFR family members in CD8(+) T-cell control of viral infections.Noncanonical Nuclear Factor Kappa B (NF-κB) Signaling and Potential for Therapeutics in Sepsis.
P2860
Q22254016-F0682DB7-0722-4DB8-A23F-2413C636C168Q22254711-E6C13886-1DC3-4730-A55E-0B76669D781DQ24534150-DEF11B9D-126F-4910-B2AF-44FBA7571736Q24534892-D5FEA719-4128-4FDB-89B7-BBBEEE7CB6D9Q24656208-48396636-9F6E-4A9F-8ECA-B28879D88801Q24670467-33CAE934-B696-4413-B38D-BA8753586F06Q26822516-F9E2082B-B2B6-4D4F-9D57-759E7C859B8EQ26853280-362D7F7E-3940-41BC-B02E-C6AFFB6C1611Q26991848-E45F2BFB-9BE4-4503-957D-0533197F264FQ28199382-7282431F-6A97-481D-B9AA-668CC2C2A8E6Q28271031-7A7B34E2-C700-4C7E-9842-A28C7ADA9F09Q28511980-0216F766-5C31-4408-AF4F-4CC79A797285Q28587065-50A8D06A-F576-46E3-B639-D1DE129EAD26Q28610678-1FDD4D7F-C5F4-4C56-8749-06B1D93AF42DQ30326707-7C59E4BA-B019-4C60-AB1E-CA2AA3A997E2Q30482040-B58E4ADF-38C9-4510-A008-449F48A631B3Q33302052-AC8B640D-4633-48D9-8875-4730FF6357FDQ33711057-CBEC6CF9-5DC8-44CC-BCED-82AD8243C2ACQ33864629-D73A86F9-1A6B-44CC-BE55-CB50E047917AQ33940420-9236001C-DD0F-4416-BADD-45FDF064D0B6Q34364910-0BA4D3BD-2CF4-4DE3-928B-F963498B2A5DQ34696221-D3B7028B-6778-4064-B880-191C0372651FQ34979007-CCFD7DC9-5CE3-47AE-BADC-031BC1A6996CQ34986884-F5EE933A-EC2C-4A66-8D54-652DB1B09EA9Q35143919-450024A6-4297-4B49-92AC-177FAD7390A3Q35951798-72FEF8E3-8A36-4981-8C1B-04E655D08D6FQ36540116-E63159FD-97F5-4BE1-8242-AC9E798BECF9Q36773555-696E7A29-7CEF-42ED-A24A-AD05AA58ACA6Q36800339-A8EA316F-EDD6-402B-9C23-5268A660C40EQ36808885-8ED811D0-52AB-4B0D-97BE-95EEEC400CEDQ36972287-65B05130-03BE-49D5-9083-58E394EE1B96Q37057398-DDEBBAA8-AE0F-4622-ACD6-C912420396CBQ37085756-2EE20B43-7595-4D13-B9E3-7256C64B66F6Q37108966-04A387B0-EEBF-4972-892E-9B3DDC47562EQ37386105-C538C9BD-B9D2-4763-801F-843F0705A646Q37474929-5A033B4D-019E-4743-8579-51158EE5914DQ37610522-4CDD2DE6-652D-49D4-A0B4-87363EE529FAQ37948123-DDB4D30E-540B-49AD-9A38-52B660615FD4Q38129083-0B65B3E6-86E2-41E5-B8DC-DB041CC8C180Q38131458-1F71875E-3008-42BB-AE62-9693FE3612EA
P2860
Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation
description
1999 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
article publié dans les Procee ...... f the United States of America
@fr
artículu científicu espublizáu en 1999
@ast
im August 1999 veröffentlichter wissenschaftlicher Artikel
@de
scientific journal article
@en
vedecký článok (publikovaný 1999/08/17)
@sk
vědecký článek publikovaný v roce 1999
@cs
wetenschappelijk artikel (gepubliceerd op 1999/08/17)
@nl
наукова стаття, опублікована в серпні 1999
@uk
name
Targeted disruption of Traf5 g ...... mediated lymphocyte activation
@ast
Targeted disruption of Traf5 g ...... mediated lymphocyte activation
@en
Targeted disruption of Traf5 g ...... mediated lymphocyte activation
@nl
type
label
Targeted disruption of Traf5 g ...... mediated lymphocyte activation
@ast
Targeted disruption of Traf5 g ...... mediated lymphocyte activation
@en
Targeted disruption of Traf5 g ...... mediated lymphocyte activation
@nl
prefLabel
Targeted disruption of Traf5 g ...... mediated lymphocyte activation
@ast
Targeted disruption of Traf5 g ...... mediated lymphocyte activation
@en
Targeted disruption of Traf5 g ...... mediated lymphocyte activation
@nl
P2093
P2860
P3181
P356
P1476
Targeted disruption of Traf5 g ...... mediated lymphocyte activation
@en
P2093
C. F. Ware
E. Munechika
K. Okumura
M. Matsumoto
M. Taniguchi
P2860
P304
P3181
P356
10.1073/PNAS.96.17.9803
P407
P577
1999-08-17T00:00:00Z